Skip to main content
Top
Published in: BMC Geriatrics 1/2021

Open Access 01-12-2021 | Sarcopenia | Research

Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program

Authors: Maryam Fathi, Ramin Heshmat, Mehdi Ebrahimi, Ahmad Salimzadeh, Afshin Ostovar, Ali Fathi, Farideh Razi, Iraj Nabipour, Maryam Moghaddassi, Gita Shafiee

Published in: BMC Geriatrics | Issue 1/2021

Login to get access

Abstract

Background

Osteosarcopenia is referred to as co-incidence of osteoporosis/osteopenia and sarcopenia which is defined as a geriatric syndrome with a significant prevalence that increases morbidity and mortality. There are some relevant factors that can show an increased risk of incidence of osteosarcopenia.

Aim

We aimed to consider the association of bone turnover markers such as Osteocalcin (OC), C-terminal cross-linked telopeptide (CTX), Tartrate Resistant acid Phosphatase (TRAP), Bone Alkaline Phosphatase (BALP) and also other factors like vitamin D, calcium, phosphorous, and ALP with osteosarcopenia in elderly.

Methods

We carried out a cross-sectional study on a random sample including 400 elder participants of Bushehr Elderly Health (BEH) study, in Iran. Osteopenia/ osteoporosis was defined as a T-score ≤ -1.0 standard deviation below the mean values of a young healthy adult. We defined sarcopenia as low muscle strength (handgrip strength<26 kg for men and <18 kg for women) with reduced skeletal muscle mass [Skeletal muscle index (SMI) < 7.0 kg/m2 for male and <5.4 kg/m2 for female]. Osteosarcopenia was considered as the presence of both osteopenia/osteoporosis and sarcopenia. We estimated the age-standardized prevalence of osteosarcopenia for men and women, separately. We used multivariable logistic regression to address the factors associated with osteosarcopenia.

Results

The results showed that there was a statistically significant difference in OC), CTX, TRAP were between the osteosarcopenia (-) and osteosarcopenia (+) groups. No statistically significant difference was observed in BALP, vitamin D, calcium, phosphorous, and ALP between the compared groups.
In the multivariable logistic regression model, OC and CTX were associated with increased likelihood of osteosarcopenia [adjusted OR= 1.023(1.002-1.045 for OC, 4.363(1.389-15.474 for CTX)]. Furthermore, TRAP increases the odds of osteosarcopenia in crude model [OR= 1.333 (1.070- 1.660)].

Conclusions

We observed the association between bone turnover markers particularly OC, CTX and osteosarcopenia. Given the rapid growth of the aging population, we should focus on geriatric diseases such as musculoskeletal disorders. Bone turnover markers maybe improve the early diagnosis, screening and assess the response to therapies in people with osteosarcopenia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Binkley N, Buehring B. Beyond FRAX: it’s time to consider” sarco-osteopenia". J Clin Densitometry. 2009;12(4):413–6.CrossRef Binkley N, Buehring B. Beyond FRAX: it’s time to consider” sarco-osteopenia". J Clin Densitometry. 2009;12(4):413–6.CrossRef
3.
go back to reference Paintin J, Cooper C, Dennison E: Osteosarcopenia. Br J Hosp Med (Lond) 2018, 79(5):253–258.CrossRef Paintin J, Cooper C, Dennison E: Osteosarcopenia. Br J Hosp Med (Lond) 2018, 79(5):253–258.CrossRef
4.
go back to reference Fuggle N, Shaw S, Dennison E, Cooper C. Sarcopenia. Best Practice Res Clin Rheumatol. 2017;31(2):218–42.CrossRef Fuggle N, Shaw S, Dennison E, Cooper C. Sarcopenia. Best Practice Res Clin Rheumatol. 2017;31(2):218–42.CrossRef
5.
go back to reference Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, Gunawardene P, Demontiero O, Duque G. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Directors Assoc. 2015;16(4):290–5.CrossRef Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Muir SW, Montero-Odasso M, Gunawardene P, Demontiero O, Duque G. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Directors Assoc. 2015;16(4):290–5.CrossRef
6.
go back to reference Fahimfar N, Zahedi Tajrishi F, Gharibzadeh S, Shafiee G, Tanha K, Heshmat R, Nabipour I, Raeisi A, Jalili A, Larijani B et al: Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program. Calcif Tissue Int 2020, 106(4):364–370.PubMedCrossRef Fahimfar N, Zahedi Tajrishi F, Gharibzadeh S, Shafiee G, Tanha K, Heshmat R, Nabipour I, Raeisi A, Jalili A, Larijani B et al: Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program. Calcif Tissue Int 2020, 106(4):364–370.PubMedCrossRef
7.
go back to reference Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R: Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord 2017, 16:21.PubMedPubMedCentralCrossRef Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R: Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord 2017, 16:21.PubMedPubMedCentralCrossRef
8.
go back to reference Shafiee G, Heshmat R, Ostovar A, Nabipour I, Larijani B. Sarcopenia disease in Iran: an overview. J Diabetes Metabolic Disorders. 2019;18(2):665–74.CrossRef Shafiee G, Heshmat R, Ostovar A, Nabipour I, Larijani B. Sarcopenia disease in Iran: an overview. J Diabetes Metabolic Disorders. 2019;18(2):665–74.CrossRef
9.
go back to reference Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N, Sanjari M, Heshmat R, Sharifi F, Mehrdad N et al: Prevalence of osteoporosis among the elderly population of Iran. Arch Osteoporos 2021, 16(1):16.PubMedCrossRef Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N, Sanjari M, Heshmat R, Sharifi F, Mehrdad N et al: Prevalence of osteoporosis among the elderly population of Iran. Arch Osteoporos 2021, 16(1):16.PubMedCrossRef
10.
go back to reference Shafiee G, Heshmat R, Ostovar A, Khatami F, Fahimfar N, Arzaghi SM, Gharibzadeh S, Hanaei S, Nabipour I, Larijani B: Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord 2020, 19(2):727–734.PubMedPubMedCentralCrossRef Shafiee G, Heshmat R, Ostovar A, Khatami F, Fahimfar N, Arzaghi SM, Gharibzadeh S, Hanaei S, Nabipour I, Larijani B: Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord 2020, 19(2):727–734.PubMedPubMedCentralCrossRef
11.
go back to reference Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives Osteoporosis. 2013;8(1):1–115. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives Osteoporosis. 2013;8(1):1–115.
12.
go back to reference Kim J, Lee Y, Kye S, Chung YS, Lee O. Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010. J Cachexia Sarcopenia Muscle. 2017;8(2):259–66.PubMedCrossRef Kim J, Lee Y, Kye S, Chung YS, Lee O. Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010. J Cachexia Sarcopenia Muscle. 2017;8(2):259–66.PubMedCrossRef
13.
go back to reference Ardawi MSM, Rouzi AA, Al-Sibiani SA, Al‐Senani NS, Qari MH, Mousa SA. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Mineral Res. 2012;27(12):2592–602.CrossRef Ardawi MSM, Rouzi AA, Al-Sibiani SA, Al‐Senani NS, Qari MH, Mousa SA. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Mineral Res. 2012;27(12):2592–602.CrossRef
14.
go back to reference Lee K. Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance. J Bone Mineral Metabolism. 2020;38(5):695–701.CrossRef Lee K. Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance. J Bone Mineral Metabolism. 2020;38(5):695–701.CrossRef
15.
go back to reference Seibel MJ: Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 2005, 26(4):97–122.PubMedPubMedCentral Seibel MJ: Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 2005, 26(4):97–122.PubMedPubMedCentral
16.
go back to reference Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metabolism. 2016;20(6):846.CrossRef Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metabolism. 2016;20(6):846.CrossRef
17.
go back to reference Kuo T-R, Chen C-H: Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker research 2017, 5(1):1–9.CrossRef Kuo T-R, Chen C-H: Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker research 2017, 5(1):1–9.CrossRef
18.
go back to reference Greenblatt MB, Tsai JN, Wein MN: Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem 2017, 63(2):464–474.PubMedCrossRef Greenblatt MB, Tsai JN, Wein MN: Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem 2017, 63(2):464–474.PubMedCrossRef
19.
go back to reference Moriwaki K, Matsumoto H, Tanishima S, Tanimura C, Osaki M, Nagashima H, Hagino H: Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study. BMC Musculoskelet Disord 2019, 20(1):276.PubMedPubMedCentralCrossRef Moriwaki K, Matsumoto H, Tanishima S, Tanimura C, Osaki M, Nagashima H, Hagino H: Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study. BMC Musculoskelet Disord 2019, 20(1):276.PubMedPubMedCentralCrossRef
20.
go back to reference Vitale JA, Sansoni V, Faraldi M, Messina C, Verdelli C, Lombardi G, Corbetta S: Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women. Front Endocrinol (Lausanne) 2021, 12:669704.CrossRef Vitale JA, Sansoni V, Faraldi M, Messina C, Verdelli C, Lombardi G, Corbetta S: Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women. Front Endocrinol (Lausanne) 2021, 12:669704.CrossRef
21.
go back to reference Mera P, Laue K, Wei J, Berger JM, Karsenty G: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol Metab 2016, 5(10):1042–1047.PubMedPubMedCentralCrossRef Mera P, Laue K, Wei J, Berger JM, Karsenty G: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice. Mol Metab 2016, 5(10):1042–1047.PubMedPubMedCentralCrossRef
22.
go back to reference Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, Fi ATig: Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 2016, 28(5):895–899.PubMedCrossRef Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, Fi ATig: Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 2016, 28(5):895–899.PubMedCrossRef
23.
go back to reference Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, Ravanipour M, Mehrdad N, Raeisi A, Heidari G et al: Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system). BMJ open 2015, 5(12):e009597.PubMedPubMedCentralCrossRef Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, Ravanipour M, Mehrdad N, Raeisi A, Heidari G et al: Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system). BMJ open 2015, 5(12):e009597.PubMedPubMedCentralCrossRef
24.
go back to reference Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A, Mehrdad N, Shadman Z, Razi F, Amini MR: Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ open 2017, 7(8):e013606.PubMedPubMedCentralCrossRef Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A, Mehrdad N, Shadman Z, Razi F, Amini MR: Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ open 2017, 7(8):e013606.PubMedPubMedCentralCrossRef
25.
go back to reference Aadahl M, Jorgensen T: Validation of a new self-report instrument for measuring physical activity. Medicine and science in sports and exercise 2003, 35(7):1196–1202.PubMedCrossRef Aadahl M, Jorgensen T: Validation of a new self-report instrument for measuring physical activity. Medicine and science in sports and exercise 2003, 35(7):1196–1202.PubMedCrossRef
26.
go back to reference Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA: A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 2011, 40(4):423–429.PubMedCrossRef Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA: A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 2011, 40(4):423–429.PubMedCrossRef
27.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G et al: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-156.CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G et al: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-156.CrossRef
28.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM et al: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412–423.PubMedPubMedCentralCrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM et al: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412–423.PubMedPubMedCentralCrossRef
29.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA: Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing 2018, 48(1):16–31.PubMedCentralCrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA: Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing 2018, 48(1):16–31.PubMedCentralCrossRef
30.
go back to reference Peck W: Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993, 94(6):646-650. Peck W: Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993, 94(6):646-650.
31.
go back to reference Group WS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843:1–129. Group WS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843:1–129.
32.
go back to reference Shafiee G, Ostovar A, Heshmat R, Keshtkar AA, Sharifi F, Shadman Z, Nabipour I, Soltani A, Larijani B: Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population. International journal of preventive medicine 2018, 9. Shafiee G, Ostovar A, Heshmat R, Keshtkar AA, Sharifi F, Shadman Z, Nabipour I, Soltani A, Larijani B: Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population. International journal of preventive medicine 2018, 9.
33.
go back to reference American Heart A, National Heart L, Blood I, Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005, 13(6):322–327.CrossRef American Heart A, National Heart L, Blood I, Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ et al: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005, 13(6):322–327.CrossRef
34.
go back to reference Hill KD, Farrier K, Russell M, Burton E. Dysmobility syndrome: current perspectives. Clin Interventions Aging. 2017;12:145–52.CrossRef Hill KD, Farrier K, Russell M, Burton E. Dysmobility syndrome: current perspectives. Clin Interventions Aging. 2017;12:145–52.CrossRef
35.
go back to reference Kirk B, Al Saedi A, Duque G: Osteosarcopenia: A case of geroscience. Aging Med (Milton) 2019, 2(3):147–156.CrossRef Kirk B, Al Saedi A, Duque G: Osteosarcopenia: A case of geroscience. Aging Med (Milton) 2019, 2(3):147–156.CrossRef
36.
go back to reference Kumari C, Yagoub G, Ashfaque M, Jawed S, Hamid P: Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus 2021, 13(3):e13820.PubMedPubMedCentral Kumari C, Yagoub G, Ashfaque M, Jawed S, Hamid P: Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus 2021, 13(3):e13820.PubMedPubMedCentral
37.
go back to reference Vs K, K P, Ramesh M, Venkatesan V: The association of serum osteocalcin with the bone mineral density in post menopausal women. J Clin Diagn Res 2013, 7(5):814–816.PubMedPubMedCentral Vs K, K P, Ramesh M, Venkatesan V: The association of serum osteocalcin with the bone mineral density in post menopausal women. J Clin Diagn Res 2013, 7(5):814–816.PubMedPubMedCentral
38.
go back to reference Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Mineral Res. 1999;14(9):1614–21.CrossRef Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Mineral Res. 1999;14(9):1614–21.CrossRef
39.
go back to reference Muraca M, Cappariello A. The role of Extracellular Vesicles (EVs) in the epigenetic regulation of bone metabolism and osteoporosis. Int J Molecular Sci. 2020;21(22):8682.CrossRef Muraca M, Cappariello A. The role of Extracellular Vesicles (EVs) in the epigenetic regulation of bone metabolism and osteoporosis. Int J Molecular Sci. 2020;21(22):8682.CrossRef
40.
go back to reference Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, Väänänen HK, Åkesson K, Obrant KJ. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Mineral Res. 2004;19(3):386–93.CrossRef Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, Väänänen HK, Åkesson K, Obrant KJ. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Mineral Res. 2004;19(3):386–93.CrossRef
41.
go back to reference Neve A, Corrado A, Cantatore FP: Osteocalcin: skeletal and extra-skeletal effects. Journal of cellular physiology 2013, 228(6):1149–1153.PubMedCrossRef Neve A, Corrado A, Cantatore FP: Osteocalcin: skeletal and extra-skeletal effects. Journal of cellular physiology 2013, 228(6):1149–1153.PubMedCrossRef
42.
go back to reference Baim S, Miller PD: Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 2009, 24(4):561–574.PubMedCrossRef Baim S, Miller PD: Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 2009, 24(4):561–574.PubMedCrossRef
43.
go back to reference Wang M, Bolland M, Grey A: Management recommendations for osteoporosis in clinical guidelines. Clin Endocrinol (Oxf) 2016, 84(5):687–692.CrossRef Wang M, Bolland M, Grey A: Management recommendations for osteoporosis in clinical guidelines. Clin Endocrinol (Oxf) 2016, 84(5):687–692.CrossRef
44.
go back to reference Tieland M, Trouwborst I, Clark BC: Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle 2018, 9(1):3–19.PubMedCrossRef Tieland M, Trouwborst I, Clark BC: Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle 2018, 9(1):3–19.PubMedCrossRef
45.
go back to reference Terracciano C, Celi M, Lecce D, Baldi J, Rastelli E, Lena E, Massa R, Tarantino U: Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis. Osteoporos Int 2013, 24(3):1095–1100.PubMedCrossRef Terracciano C, Celi M, Lecce D, Baldi J, Rastelli E, Lena E, Massa R, Tarantino U: Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis. Osteoporos Int 2013, 24(3):1095–1100.PubMedCrossRef
46.
go back to reference Girgis CM, Cha KM, So B, Tsang M, Chen J, Houweling PJ, Schindeler A, Stokes R, Swarbrick MM, Evesson FJ et al: Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. J Cachexia Sarcopenia Muscle 2019, 10(6):1228–1240.PubMedPubMedCentralCrossRef Girgis CM, Cha KM, So B, Tsang M, Chen J, Houweling PJ, Schindeler A, Stokes R, Swarbrick MM, Evesson FJ et al: Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. J Cachexia Sarcopenia Muscle 2019, 10(6):1228–1240.PubMedPubMedCentralCrossRef
47.
go back to reference Kim YM, Kim S, Won YJ, Kim SH. Clinical manifestations and factors associated with osteosarcopenic obesity syndrome: a cross-sectional study in koreans with obesity. Calcified Tissue Int. 2019;105(1):77–88.CrossRef Kim YM, Kim S, Won YJ, Kim SH. Clinical manifestations and factors associated with osteosarcopenic obesity syndrome: a cross-sectional study in koreans with obesity. Calcified Tissue Int. 2019;105(1):77–88.CrossRef
48.
go back to reference Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Population Nutrition. 2011;29(2):149.CrossRef Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Population Nutrition. 2011;29(2):149.CrossRef
49.
go back to reference Bruyère O, Cavalier E, Reginster J-Y. Vitamin D and osteosarcopenia: an update from epidemiological studies. Curr Opinion Clin Nutrition Metabolic Care. 2017;20(6):498.CrossRef Bruyère O, Cavalier E, Reginster J-Y. Vitamin D and osteosarcopenia: an update from epidemiological studies. Curr Opinion Clin Nutrition Metabolic Care. 2017;20(6):498.CrossRef
Metadata
Title
Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program
Authors
Maryam Fathi
Ramin Heshmat
Mehdi Ebrahimi
Ahmad Salimzadeh
Afshin Ostovar
Ali Fathi
Farideh Razi
Iraj Nabipour
Maryam Moghaddassi
Gita Shafiee
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2021
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-021-02608-w

Other articles of this Issue 1/2021

BMC Geriatrics 1/2021 Go to the issue